Springbok Analytics

Springbok Analytics develops an FDA-cleared AI platform that transforms standard MRI data into high-resolution 3D musculoskeletal analyses, creating personalized digital twins of individual muscles. The platform quantifies over 100 individual muscles across the legs, core, back, chest, shoulders, and arms, measuring muscle volume, fat infiltration, and symmetry with pixel-level precision. Scans are processed within 24 hours using AI-driven software, delivering detailed reports with 3D visualizations through an interactive web-based viewer. Springbok serves three primary markets: research and clinical trials (standardized muscle data for drug development), elite sports (return-to-play decisions and performance optimization), and longevity and preventive health (tracking muscle health over time). The technology also analyzes tendons, bone, scar tissue, and body composition from a single scan. Founded in 2013 and headquartered in Charlottesville, United States, the company has raised approximately $8 million at the Series A stage.